TickerFactsScreenerDevelopers

MoonLake Immunotherapeutics (MLTX) — Shares Outstanding

Annual figures by fiscal year, from SEC filings.

2021: 360.00M2022: 29.36M2023: 49.12M2024: 62.87M2025: 64.46M64.46M
2021Shares Outstanding (shares)2025
Fiscal YearShares OutstandingChange YoY
202564.46M+2.5%
202462.87M+28.0%
202349.12M+67.3%
202229.36M-91.8%
2021360.00M—